List/Grid CRISPR Therapeutic

CRISPR gene editing reveals new therapeutic approach for sickle cell disease

An international team of scientists led by researchers at St. Jude Children’s Research Hospital has found a way to use CRISPR gene editing to help fix sickle cell disease and beta-thalassemia ...

Broad Institute, Harvard, and MIT license CRISPR-Cas9 technology to Editas

The Broad Institute, Harvard University, the Massachusetts Institute of Technology and Editas Medicine have entered into a
© 3614 CRISPR tools and Resources. All rights reserved.